Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  CloudMD Software & Services Inc.    DOC   CA18912C1023

CLOUDMD SOFTWARE & SERVICES INC.

(DOC)
  Report
SummaryQuotesNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
The feature you requested does not exist. However, we suggest the following feature:

CloudMD Software & Services : Announces Commencement of Trading on the TSX Venture Exchange

share with twitter share with LinkedIn share with facebook
06/04/2020 | 07:31am EDT

TORONTO, June 04, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV:DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company seeking to revolutionize the delivery of healthcare to patients, is pleased to announce that, effective at market open today, it has commenced trading its common shares on the TSX Venture Exchange (the “TSXV”).

The Company will continue to trade under its symbol “DOC”. The CUSIP 18912C102 and ISIN CA18912C1023 will remain the same.   

The Company’s common shares have been delisted from the Canadian Securities Exchange. Shareholders of the Company are not required to take any action with respect to their shareholdings in connection with the Company’s listing on the TSXV.

Listed Warrants

Further to the Company’s news release of June 2, 2020, the Company issued 10,678,900 warrants (the “Warrants”) on the Canadian Securities Exchange.

Each Warrant is exercisable to acquire one common share of the Company for a period of 24 months from closing of the transaction at an exercise price of $1.00 per Warrant.

The Warrants will continue to be listed on the Canadian Securities Exchange under CUSIP 18912C136 until further notice.

About CloudMD Software & Services

CloudMD is digitizing the delivery of healthcare by providing patients access to all points of their care from their phone, tablet or desktop computer. The Company offers SAAS based health technology solutions to medical clinics across Canada and has developed proprietary technology that delivers quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). CloudMD currently provides service to a combined ecosystem of 376 clinics, over 3000 licensed practitioners and almost 3 million patient charts across its servers.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

ON BEHALF OF THE BOARD OF DIRECTORS

“Dr. Essam Hamza, MD"
Chief Executive Officer

FOR ADDITIONAL INFORMATION CONTACT:

CloudMD Software & Services Inc.
investors.cloudmd.ca
Email: investors@cloudmd.ca

Forward Looking Statements

This news release contains forward-looking statements that are based on CloudMD’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans, listing on the TSXV and its intended use of the proceeds of the Offering. Although CloudMD believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and CloudMD undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

The Toronto Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.


cloud.jpg

Source: CloudMD Software & Services Inc.

2020 GlobeNewswire, Inc., source Press Releases

share with twitter share with LinkedIn share with facebook
All news about CLOUDMD SOFTWARE & SERVICE
06/04CLOUDMD SOFTWARE & SERVICES : Announces Commencement of Trading on the TSX Ventu..
AQ
06/03CSE BULLETIN : Delist - CloudMD Software & Services Inc. (DOC)
NE
06/01CLOUDMD SOFTWARE & SERVICES : Reports Record Q1 2020 Revenue of $3.1 Million
AQ
05/21CLOUDMD SOFTWARE & SERVICES : Clinic Doctor, Tahmeena Ali, Honoured as BC's Top ..
AQ
05/14CLOUDMD SOFTWARE & SERVICES : Welcomes Mark Kohler as Chairman of the Board
AQ
05/13CLOUDMD SOFTWARE & SERVICES : Announces an Increase to Previously Announced Boug..
AQ
05/13CLOUDMD SOFTWARE & SERVICES : IIROC Trade Resumption - DOC
AQ
05/12CLOUDMD SOFTWARE & SERVICES : Announces $10 Million Bought Deal Public Offering
AQ
05/12CLOUDMD SOFTWARE & SERVICES : IIROC Trading Halt - DOC
AQ
05/07CLOUDMD SOFTWARE & SERVICES : Partners with Innovative Technology Leader IDYA4 C..
AQ
More news
Financials
Sales 2020 17,5 M 13,2 M 13,2 M
Net income 2020 -4,08 M -3,09 M -3,09 M
Net cash 2020 26,3 M 19,9 M 19,9 M
P/E ratio 2020 -18,0x
Yield 2020 -
Capitalization 90,8 M 68,8 M 68,7 M
EV / Sales 2020 3,69x
EV / Sales 2021 1,64x
Nbr of Employees -
Free-Float 81,9%
Chart CLOUDMD SOFTWARE & SERVICES INC.
Duration : Period :
CloudMD Software & Services Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 1,53 CAD
Last Close Price 0,84 CAD
Spread / Highest target 138%
Spread / Average Target 82,5%
Spread / Lowest Target 42,9%
EPS Revisions
Managers
NameTitle
Essam Hamza Chief Executive Officer & Director
Amit Mathur President & Director
Mark William Kohler Chairman
Kanchan Thindal Chief Operating Officer
Mena Beshay Chief Financial Officer
Sector and Competitors